[1]Fliedner S M, Lehnert H, Pacak K. Metastatic paraganglioma[J].Semin Oncol,2010,37(6):627 [2]Stolk R, Bakx C, Mulder J, et al. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines[J]. Clin Endocri nol Metab.March ,2013,98(3):1100 [3]周建军,程伟中,曾维新,等. 腹部肾上腺外嗜铬细胞瘤:双期增强的影像学诊断价值[J].放射学实践,2007,10(10):1058 [4]Taïeb D, Sebag F, Barlier A, et al.18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature[J].J Nucl Med, 2009,50(5):711 [5]van Berkel A, Rao J U, Kusters B, et al. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma[J]. J Nucl Med,2014,55(8):1253 [6]Bittner J G, Brunt L M. Evaluation and management of adrenal incidentaloma[J]. J Surg Oncol,2012,106(5):557 [7]Farzin I, Vatche G, Agopian, et al. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas[J].J Nucl Med,2009,50:513 [8]Yamamoto S, Wassberg C, Hellman P, et al. 11C-Hydroxyephedrine positron emission tomography in the postoperative management of pheochromocytoma and paraganglioma:a single center experience over 11 years[J].J Clin Endocrinol Metab,2012,97(7):2422
[1]王亮,李黎明.副神经节瘤的诊治现状及进展[J].天津医科大学学报,2013,19(05):430.